| regulation of fatty acid metabolic process | GO:0019217 | 28 | 1.000 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.999 | |
| positive regulation of triglyceride metabolic process | GO:0090208 | 9 | 0.998 | |
| cholesterol storage | GO:0010878 | 4 | 0.997 | |
| glycerolipid catabolic process | GO:0046503 | 16 | 0.995 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.995 | |
| response to peptide hormone | GO:0043434 | 127 | 0.995 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.994 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.993 | |
| coagulation | GO:0050817 | 78 | 0.990 | Human |
| mapk cascade | GO:0000165 | 281 | 0.989 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.987 | |
| cellular response to peptide | GO:1901653 | 92 | 0.987 | |
| acylglycerol catabolic process | GO:0046464 | 11 | 0.987 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.979 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.979 | |
| lipid homeostasis | GO:0055088 | 63 | 0.975 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.972 | |
| regulation of lipid catabolic process | GO:0050994 | 15 | 0.967 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.966 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.966 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.964 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.960 | |
| regulation of nitrogen cycle metabolic process | GO:1903314 | 1 | 0.958 | |
| response to low density lipoprotein particle | GO:0055098 | 2 | 0.958 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.957 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.956 | |
| positive regulation of fatty acid oxidation | GO:0046321 | 4 | 0.956 | |
| triglyceride catabolic process | GO:0019433 | 9 | 0.951 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.948 | |
| oxidation reduction process | GO:0055114 | 342 | 0.942 | |
| sensory perception of umami taste | GO:0050917 | 4 | 0.942 | |
| regulation of fatty acid oxidation | GO:0046320 | 10 | 0.941 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.940 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.939 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.938 | |
| regulation of glutamine family amino acid metabolic process | GO:0000820 | 1 | 0.937 | |
| regulation of triglyceride metabolic process | GO:0090207 | 17 | 0.933 | |
| angiogenesis | GO:0001525 | 201 | 0.923 | |
| regulation of phosphatidylcholine catabolic process | GO:0010899 | 2 | 0.922 | |
| lactation | GO:0007595 | 25 | 0.920 | |
| regulation of phospholipid catabolic process | GO:0060696 | 2 | 0.918 | |
| fatty acid oxidation | GO:0019395 | 28 | 0.910 | |
| termination of rna polymerase i transcription | GO:0006363 | 2 | 0.908 | |
| amine metabolic process | GO:0009308 | 45 | 0.899 | |
| response to testosterone | GO:0033574 | 3 | 0.893 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.890 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.880 | Mouse |
| wound healing | GO:0042060 | 157 | 0.878 | Human Mouse |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.876 | |
| negative regulation of interferon gamma mediated signaling pathway | GO:0060336 | 1 | 0.874 | |
| cellular response to increased oxygen levels | GO:0036295 | 1 | 0.874 | Human |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.871 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.871 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.866 | |
| drug catabolic process | GO:0042737 | 2 | 0.864 | |
| response to alkaloid | GO:0043279 | 34 | 0.862 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.861 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.858 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.856 | |
| hair cycle | GO:0042633 | 90 | 0.854 | |
| sequestering of triglyceride | GO:0030730 | 6 | 0.851 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.844 | Mouse |
| ammonia assimilation cycle | GO:0019676 | 2 | 0.840 | |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.834 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.824 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.816 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.812 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.812 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.810 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.806 | |
| epidermis development | GO:0008544 | 187 | 0.805 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.804 | Human |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.803 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.800 | |
| dna templated transcription termination | GO:0006353 | 4 | 0.800 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.794 | |
| positive regulation of triglyceride catabolic process | GO:0010898 | 3 | 0.794 | |
| response to hypoxia | GO:0001666 | 58 | 0.790 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.782 | |
| response to purine containing compound | GO:0014074 | 28 | 0.780 | |
| lipid catabolic process | GO:0016042 | 69 | 0.776 | |
| protein localization to organelle | GO:0033365 | 185 | 0.775 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.772 | |
| intestinal cholesterol absorption | GO:0030299 | 5 | 0.762 | Zebrafish |
| response to organic cyclic compound | GO:0014070 | 198 | 0.743 | |
| transcription initiation from rna polymerase i promoter | GO:0006361 | 4 | 0.742 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.741 | |
| hair follicle development | GO:0001942 | 85 | 0.738 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.735 | |
| neutral lipid catabolic process | GO:0046461 | 11 | 0.735 | |
| neutral lipid biosynthetic process | GO:0046460 | 18 | 0.730 | |
| regulation of vitamin d biosynthetic process | GO:0060556 | 1 | 0.727 | |
| regulation of urea metabolic process | GO:0034255 | 1 | 0.726 | |
| glucose homeostasis | GO:0042593 | 128 | 0.722 | Mouse |
| regulation of lipid storage | GO:0010883 | 20 | 0.720 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.719 | |
| tissue homeostasis | GO:0001894 | 115 | 0.713 | |
| response to increased oxygen levels | GO:0036296 | 2 | 0.712 | Human |
| regulation of protein targeting | GO:1903533 | 61 | 0.711 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.703 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.695 | Mouse |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.691 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.691 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.687 | |
| regulation of vitamin metabolic process | GO:0030656 | 3 | 0.676 | |
| skeletal system development | GO:0001501 | 356 | 0.676 | |
| response to nitric oxide | GO:0071731 | 4 | 0.673 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.669 | Worm |
| keratinocyte migration | GO:0051546 | 3 | 0.667 | |
| membrane assembly | GO:0071709 | 12 | 0.662 | |
| cellular response to prostaglandin stimulus | GO:0071379 | 2 | 0.658 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.654 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.653 | Mouse |
| acylglycerol homeostasis | GO:0055090 | 16 | 0.651 | |
| dna metabolic process | GO:0006259 | 303 | 0.646 | |
| membrane biogenesis | GO:0044091 | 12 | 0.646 | |
| gas homeostasis | GO:0033483 | 3 | 0.645 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.642 | Worm |
| regulation of the force of heart contraction | GO:0002026 | 17 | 0.640 | |
| monocarboxylic acid catabolic process | GO:0072329 | 27 | 0.638 | |
| response to peptide | GO:1901652 | 136 | 0.637 | |
| heart process | GO:0003015 | 94 | 0.634 | |
| circadian rhythm | GO:0007623 | 114 | 0.634 | |
| regulation of response to food | GO:0032095 | 10 | 0.625 | |
| response to monosaccharide | GO:0034284 | 67 | 0.622 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.620 | |
| response to bile acid | GO:1903412 | 1 | 0.615 | |
| regulation of insulin receptor signaling pathway | GO:0046626 | 21 | 0.614 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.613 | |
| regulation of receptor activity | GO:0010469 | 41 | 0.613 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.611 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.610 | |
| lipid transport | GO:0006869 | 98 | 0.605 | Zebrafish Worm |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.603 | |
| trachea development | GO:0060438 | 18 | 0.602 | |
| regulation of protein kinase b signaling | GO:0051896 | 56 | 0.597 | Mouse |
| membrane raft assembly | GO:0001765 | 3 | 0.596 | |
| regulation of the force of heart contraction by chemical signal | GO:0003057 | 5 | 0.592 | |
| heart contraction | GO:0060047 | 93 | 0.584 | |
| response to insulin | GO:0032868 | 100 | 0.584 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.582 | |
| activation of janus kinase activity | GO:0042976 | 2 | 0.580 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.578 | |
| interleukin 18 mediated signaling pathway | GO:0035655 | 2 | 0.572 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.565 | |
| response to lipoprotein particle | GO:0055094 | 5 | 0.563 | |
| positive regulation of cyclic nucleotide biosynthetic process | GO:0030804 | 24 | 0.562 | |
| phospholipid catabolic process | GO:0009395 | 5 | 0.562 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.558 | Human |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.547 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.546 | Mouse |
| protein nitrosylation | GO:0017014 | 4 | 0.546 | |
| sterol homeostasis | GO:0055092 | 45 | 0.543 | |
| triglyceride biosynthetic process | GO:0019432 | 17 | 0.543 | |
| triglyceride homeostasis | GO:0070328 | 15 | 0.541 | |
| response to vitamin a | GO:0033189 | 1 | 0.541 | |
| intestinal absorption | GO:0050892 | 13 | 0.537 | Zebrafish |
| negative regulation of release of cytochrome c from mitochondria | GO:0090201 | 6 | 0.536 | |
| regulation of cell migration | GO:0030334 | 219 | 0.530 | |
| regulation of ammonia assimilation cycle | GO:2001248 | 1 | 0.527 | |
| microtubule based process | GO:0007017 | 236 | 0.520 | Mouse |
| cellular response to external stimulus | GO:0071496 | 88 | 0.514 | Human |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.513 | |
| creatine metabolic process | GO:0006600 | 4 | 0.510 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.508 | |
| nitric oxide metabolic process | GO:0046209 | 25 | 0.507 | |
| regulation of generation of precursor metabolites and energy | GO:0043467 | 38 | 0.506 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.502 | |
| body fluid secretion | GO:0007589 | 53 | 0.500 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.500 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.499 | |
| plasma lipoprotein particle clearance | GO:0034381 | 13 | 0.498 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.490 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.488 | |
| urogenital system development | GO:0001655 | 261 | 0.483 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.481 | |
| establishment of protein localization to membrane | GO:0090150 | 54 | 0.480 | Mouse |
| creatinine metabolic process | GO:0046449 | 3 | 0.479 | |
| cellular response to bile acid | GO:1903413 | 1 | 0.479 | |
| cholesterol transport | GO:0030301 | 38 | 0.478 | Zebrafish |
| single organism nuclear import | GO:1902593 | 95 | 0.475 | |
| adrenergic receptor signaling pathway | GO:0071875 | 13 | 0.474 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.474 | |
| glutamine family amino acid metabolic process | GO:0009064 | 15 | 0.470 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.468 | Human |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.467 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.467 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.465 | Mouse |
| response to amphetamine | GO:0001975 | 16 | 0.462 | |
| receptor biosynthetic process | GO:0032800 | 3 | 0.459 | |
| negative regulation of protein kinase b signaling | GO:0051898 | 18 | 0.458 | |
| positive regulation of glycogen metabolic process | GO:0070875 | 8 | 0.457 | |
| sterol transmembrane transport | GO:0035382 | 2 | 0.456 | |
| negative regulation of reactive oxygen species biosynthetic process | GO:1903427 | 0 | 0.456 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.455 | |
| positive regulation of phagocytosis engulfment | GO:0060100 | 3 | 0.453 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.452 | |
| eye photoreceptor cell development | GO:0042462 | 31 | 0.451 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.450 | |
| tyrosine phosphorylation of stat5 protein | GO:0042506 | 9 | 0.448 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.447 | |
| response to oxygen levels | GO:0070482 | 62 | 0.442 | |
| multicellular organism growth | GO:0035264 | 161 | 0.438 | |
| regulation of androgen receptor signaling pathway | GO:0060765 | 3 | 0.437 | |
| positive regulation of smooth muscle cell migration | GO:0014911 | 4 | 0.435 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.435 | |
| positive regulation of lipid storage | GO:0010884 | 10 | 0.434 | |
| phototransduction | GO:0007602 | 17 | 0.434 | |
| regulation of adrenergic receptor signaling pathway | GO:0071877 | 4 | 0.429 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.428 | |
| response to nutrient levels | GO:0031667 | 109 | 0.426 | Human |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.426 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 43 | 0.426 | |
| response to estrogen | GO:0043627 | 24 | 0.422 | |
| cellular response to vitamin | GO:0071295 | 2 | 0.419 | |
| placenta development | GO:0001890 | 140 | 0.417 | |
| pyruvate metabolic process | GO:0006090 | 28 | 0.415 | |
| lipid modification | GO:0030258 | 65 | 0.414 | |
| positive regulation of nucleotide biosynthetic process | GO:0030810 | 26 | 0.413 | |
| triglyceride mobilization | GO:0006642 | 5 | 0.408 | |
| negative regulation of map kinase activity | GO:0043407 | 34 | 0.408 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.405 | |
| platelet activation | GO:0030168 | 40 | 0.405 | |
| muscle cell cellular homeostasis | GO:0046716 | 12 | 0.405 | Mouse |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.399 | |
| regulation of receptor biosynthetic process | GO:0010869 | 2 | 0.397 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.397 | Human |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.397 | |
| cellular response to interleukin 18 | GO:0071351 | 3 | 0.396 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.395 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.392 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.391 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.390 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.385 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.381 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.380 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.379 | |
| inflammatory response to wounding | GO:0090594 | 4 | 0.376 | |
| rhodopsin mediated signaling pathway | GO:0016056 | 4 | 0.376 | |
| regulation of intestinal cholesterol absorption | GO:0030300 | 4 | 0.375 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.373 | |
| regulation of protein import into nucleus | GO:0042306 | 52 | 0.371 | |
| positive regulation of myeloid leukocyte differentiation | GO:0002763 | 26 | 0.371 | |
| nitric oxide mediated signal transduction | GO:0007263 | 4 | 0.367 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.366 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.363 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.361 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.361 | Mouse |
| stem cell differentiation | GO:0048863 | 268 | 0.360 | |
| macrophage derived foam cell differentiation | GO:0010742 | 6 | 0.360 | |
| adenylate cyclase activating dopamine receptor signaling pathway | GO:0007191 | 7 | 0.359 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.358 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.358 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.356 | |
| negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway | GO:1902176 | 4 | 0.354 | |
| regulation of steroid biosynthetic process | GO:0050810 | 26 | 0.353 | |
| negative regulation of sequestering of triglyceride | GO:0010891 | 2 | 0.352 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.349 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.348 | |
| negative regulation of systemic arterial blood pressure | GO:0003085 | 15 | 0.346 | |
| connective tissue development | GO:0061448 | 179 | 0.344 | |
| p38mapk cascade | GO:0038066 | 4 | 0.343 | Mouse |
| cellular response to bacterial lipoprotein | GO:0071220 | 3 | 0.342 | |
| endocytosis | GO:0006897 | 168 | 0.342 | Human Mouse |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.340 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.339 | |
| regulation of endothelial cell proliferation | GO:0001936 | 23 | 0.336 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.335 | |
| positive regulation of adrenergic receptor signaling pathway | GO:0071879 | 3 | 0.334 | |
| mammary gland lobule development | GO:0061377 | 22 | 0.334 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.331 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.329 | |
| response to caffeine | GO:0031000 | 6 | 0.328 | |
| lipoprotein transport | GO:0042953 | 7 | 0.328 | |
| hemostasis | GO:0007599 | 78 | 0.327 | Human |
| glucose import | GO:0046323 | 32 | 0.326 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.326 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.323 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.320 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.318 | |
| lipid localization | GO:0010876 | 126 | 0.316 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.316 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.314 | |
| fatty acid catabolic process | GO:0009062 | 25 | 0.312 | |
| regulation of response to oxidative stress | GO:1902882 | 19 | 0.312 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.311 | |
| positive regulation of creb transcription factor activity | GO:0032793 | 4 | 0.310 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.310 | |
| transcription from rna polymerase i promoter | GO:0006360 | 13 | 0.308 | |
| negative regulation of androgen receptor signaling pathway | GO:0060766 | 3 | 0.306 | |
| regulation of carbohydrate biosynthetic process | GO:0043255 | 40 | 0.303 | |
| positive regulation of fatty acid metabolic process | GO:0045923 | 8 | 0.302 | |
| positive regulation of bone remodeling | GO:0046852 | 13 | 0.302 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.301 | |
| regulation of serotonin uptake | GO:0051611 | 2 | 0.297 | |
| regulation of calcidiol 1 monooxygenase activity | GO:0060558 | 1 | 0.297 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.296 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.295 | |
| regulation of removal of superoxide radicals | GO:2000121 | 4 | 0.294 | |
| regulation of monooxygenase activity | GO:0032768 | 7 | 0.294 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.294 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.294 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.294 | |
| lipid oxidation | GO:0034440 | 29 | 0.289 | |
| g protein coupled acetylcholine receptor signaling pathway | GO:0007213 | 4 | 0.289 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.289 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.287 | |
| negative regulation of endothelial cell proliferation | GO:0001937 | 8 | 0.287 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.281 | |
| blood coagulation | GO:0007596 | 76 | 0.281 | Human |
| g protein coupled receptor signaling pathway involved in heart process | GO:0086103 | 4 | 0.279 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.279 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.279 | Human |
| positive regulation of osteoclast differentiation | GO:0045672 | 15 | 0.279 | |
| ossification | GO:0001503 | 216 | 0.279 | |
| serotonin receptor signaling pathway | GO:0007210 | 8 | 0.278 | |
| acylglycerol biosynthetic process | GO:0046463 | 18 | 0.278 | |
| negative regulation of tyrosine phosphorylation of stat5 protein | GO:0042524 | 2 | 0.275 | |
| tyrosine phosphorylation of stat protein | GO:0007260 | 23 | 0.270 | |
| response to oxidative stress | GO:0006979 | 123 | 0.269 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.269 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.267 | |
| urea metabolic process | GO:0019627 | 3 | 0.266 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.265 | Human |
| positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902043 | 13 | 0.264 | |
| embryonic placenta development | GO:0001892 | 98 | 0.264 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.263 | |
| cellular response to lipid | GO:0071396 | 145 | 0.261 | |
| regulation of triglyceride biosynthetic process | GO:0010866 | 10 | 0.260 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.260 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.259 | Human |
| regulation of triglyceride catabolic process | GO:0010896 | 5 | 0.259 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.259 | |
| positive regulation of coagulation | GO:0050820 | 13 | 0.258 | |
| retinal cone cell development | GO:0046549 | 8 | 0.257 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.257 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.254 | |
| cyclic nucleotide mediated signaling | GO:0019935 | 18 | 0.251 | |
| labyrinthine layer development | GO:0060711 | 49 | 0.250 | |
| regulation of secretion | GO:0051046 | 274 | 0.249 | |
| positive regulation of lipid catabolic process | GO:0050996 | 6 | 0.249 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.249 | |
| regulation of cholesterol storage | GO:0010885 | 4 | 0.248 | |
| blood circulation | GO:0008015 | 195 | 0.247 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.244 | |
| regulation of wound healing | GO:0061041 | 40 | 0.243 | Human |
| platelet derived growth factor receptor signaling pathway | GO:0048008 | 32 | 0.241 | |
| glutamine metabolic process | GO:0006541 | 8 | 0.239 | |
| response to corticosteroid | GO:0031960 | 20 | 0.239 | |
| superoxide metabolic process | GO:0006801 | 27 | 0.237 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.236 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.236 | |
| positive regulation by symbiont of defense related host nitric oxide production | GO:0052347 | 1 | 0.236 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.235 | Human |
| apoptotic process involved in mammary gland involution | GO:0060057 | 4 | 0.233 | |
| cell adhesion | GO:0007155 | 329 | 0.230 | |
| glycolytic process | GO:0006096 | 20 | 0.230 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.229 | |
| regulation of carbohydrate catabolic process | GO:0043470 | 12 | 0.228 | |
| positive regulation of histone modification | GO:0031058 | 28 | 0.226 | |
| response to fatty acid | GO:0070542 | 8 | 0.225 | |
| cellular homeostasis | GO:0019725 | 240 | 0.223 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.223 | |
| taurine metabolic process | GO:0019530 | 4 | 0.223 | |
| response to hyperoxia | GO:0055093 | 2 | 0.223 | Human |
| metanephric nephron development | GO:0072210 | 34 | 0.222 | |
| positive regulation of lipid biosynthetic process | GO:0046889 | 18 | 0.222 | |
| negative regulation of peptide hormone secretion | GO:0090278 | 16 | 0.221 | |
| bone development | GO:0060348 | 120 | 0.221 | |
| regulation of gluconeogenesis | GO:0006111 | 30 | 0.220 | |
| response to glucocorticoid | GO:0051384 | 20 | 0.220 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.219 | |
| regulation of immune complex clearance by monocytes and macrophages | GO:0090264 | 2 | 0.218 | |
| positive regulation of apoptotic process involved in morphogenesis | GO:1902339 | 4 | 0.217 | |
| isoleucine metabolic process | GO:0006549 | 4 | 0.217 | |
| protein targeting | GO:0006605 | 143 | 0.217 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.216 | |
| negative regulation of blood pressure | GO:0045776 | 22 | 0.215 | |
| energy reserve metabolic process | GO:0006112 | 39 | 0.215 | |
| protein localization to membrane | GO:0072657 | 108 | 0.214 | Mouse |
| cerebral cortex development | GO:0021987 | 86 | 0.214 | |
| response to lithium ion | GO:0010226 | 10 | 0.214 | |
| photoreceptor cell differentiation | GO:0046530 | 52 | 0.214 | |
| cellular carbohydrate catabolic process | GO:0044275 | 15 | 0.213 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.210 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.208 | |
| negative regulation of growth | GO:0045926 | 99 | 0.207 | |
| regulation of response to reactive oxygen species | GO:1901031 | 9 | 0.205 | |
| circulatory system process | GO:0003013 | 197 | 0.204 | |
| response to vitamin | GO:0033273 | 6 | 0.202 | |
| positive regulation of vasoconstriction | GO:0045907 | 4 | 0.202 | |
| genetic imprinting | GO:0071514 | 27 | 0.202 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.202 | |
| response to drug | GO:0042493 | 75 | 0.201 | |
| negative regulation of cellular response to insulin stimulus | GO:1900077 | 16 | 0.201 | |
| regulation of coagulation | GO:0050818 | 31 | 0.200 | Human |
| telencephalon development | GO:0021537 | 186 | 0.200 | |
| regulation of nuclear division | GO:0051783 | 56 | 0.199 | |
| positive regulation of macrophage derived foam cell differentiation | GO:0010744 | 4 | 0.199 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.198 | |
| rhythmic process | GO:0048511 | 174 | 0.198 | |
| positive regulation of fat cell differentiation | GO:0045600 | 32 | 0.197 | |
| nuclear transport | GO:0051169 | 139 | 0.196 | |
| regulation of pigment cell differentiation | GO:0050932 | 7 | 0.196 | |
| positive regulation of cholesterol transport | GO:0032376 | 9 | 0.195 | |
| membrane organization | GO:0061024 | 245 | 0.194 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.194 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.192 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.191 | |
| plasma membrane long chain fatty acid transport | GO:0015911 | 1 | 0.191 | |
| response to ph | GO:0009268 | 14 | 0.190 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.190 | |
| tyrosine phosphorylation of stat1 protein | GO:0042508 | 3 | 0.190 | |
| regulation of appetite | GO:0032098 | 12 | 0.188 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.188 | |
| metanephric glomerular mesangial cell proliferation involved in metanephros development | GO:0072262 | 3 | 0.188 | |
| cholesterol import | GO:0070508 | 2 | 0.187 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.186 | |
| response to defense related nitric oxide production by other organism involved in symbiotic interaction | GO:0052551 | 2 | 0.184 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.183 | Human |
| positive regulation of cell death | GO:0010942 | 224 | 0.183 | Human |
| response to estradiol | GO:0032355 | 12 | 0.182 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.180 | |
| forebrain development | GO:0030900 | 302 | 0.180 | |
| sterol metabolic process | GO:0016125 | 58 | 0.179 | |
| kidney development | GO:0001822 | 213 | 0.177 | |
| fatty acid transmembrane transport | GO:1902001 | 1 | 0.177 | |
| vitamin d biosynthetic process | GO:0042368 | 3 | 0.177 | |
| tissue remodeling | GO:0048771 | 102 | 0.176 | |
| negative regulation of peptide secretion | GO:0002792 | 16 | 0.175 | |
| regulation of cell motility | GO:2000145 | 236 | 0.174 | |
| camp metabolic process | GO:0046058 | 40 | 0.172 | |
| regulation of melanocyte differentiation | GO:0045634 | 7 | 0.172 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.170 | Mouse |
| fatty acid beta oxidation | GO:0006635 | 16 | 0.170 | |
| dna methylation | GO:0006306 | 43 | 0.169 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.169 | |
| nuclear envelope organization | GO:0006998 | 11 | 0.168 | |
| glutamate receptor signaling pathway | GO:0007215 | 35 | 0.168 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.167 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.167 | |
| lipid storage | GO:0019915 | 36 | 0.167 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.167 | Mouse |
| anatomical structure maturation | GO:0071695 | 49 | 0.166 | |
| peptidyl cysteine modification | GO:0018198 | 8 | 0.165 | |
| tissue migration | GO:0090130 | 68 | 0.165 | |
| response to fructose | GO:0009750 | 2 | 0.164 | |
| metanephric glomerular mesangium development | GO:0072223 | 3 | 0.163 | |
| regulation of histone acetylation | GO:0035065 | 19 | 0.163 | |
| regulation of sequestering of triglyceride | GO:0010889 | 6 | 0.163 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.161 | Human |
| regulation of histone deacetylation | GO:0031063 | 12 | 0.161 | |
| cardiac chamber development | GO:0003205 | 108 | 0.161 | Mouse |
| eye photoreceptor cell differentiation | GO:0001754 | 41 | 0.160 | |
| sterol transport | GO:0015918 | 38 | 0.160 | Zebrafish |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.160 | |
| glycogen biosynthetic process | GO:0005978 | 14 | 0.159 | |
| regulation of protein import into nucleus translocation | GO:0033158 | 2 | 0.159 | |
| regulation of g protein coupled receptor protein signaling pathway | GO:0008277 | 37 | 0.158 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.158 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.158 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.157 | |
| action potential | GO:0001508 | 78 | 0.156 | |
| negative regulation of neurotransmitter uptake | GO:0051581 | 2 | 0.156 | |
| response to food | GO:0032094 | 17 | 0.155 | |
| prolactin signaling pathway | GO:0038161 | 5 | 0.155 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.154 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.154 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.153 | |
| macromolecule methylation | GO:0043414 | 120 | 0.153 | |
| protein catabolic process | GO:0030163 | 221 | 0.152 | |
| cell fate commitment | GO:0045165 | 210 | 0.151 | |
| nuclear import | GO:0051170 | 95 | 0.151 | |
| response to inorganic substance | GO:0010035 | 96 | 0.150 | |
| dna templated transcription initiation | GO:0006352 | 13 | 0.150 | |
| regulation of osteoclast differentiation | GO:0045670 | 36 | 0.149 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.148 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.148 | |
| response to epidermal growth factor | GO:0070849 | 4 | 0.147 | |
